Zobrazeno 1 - 10 of 278 pro vyhledávání: '"Khetarpal V"'
1
Akademický článek
Preclinical evaluation of the novel [ 18 F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease.
Autor: Zajicek F; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium., Verhaeghe J; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium., De Lombaerde S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium., Van Eetveldt A; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium., Miranda A; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium., Munoz-Sanjuan I; CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, CA, USA., Dominguez C; CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, CA, USA., Khetarpal V; CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, CA, USA., Bard J; CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, CA, USA., Liu L; CHDI Management, Inc., the company that manages the scientific activities of CHDI Foundation, Inc., Los Angeles, CA, USA., Staelens S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium., Bertoglio D; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium. daniele.bertoglio@uantwerpen.be.; Bio-Imaging Lab, University of Antwerp, Antwerp, Belgium. daniele.bertoglio@uantwerpen.be.; µNeuro Centre of Excellence, University of Antwerp, Antwerp, Belgium. daniele.bertoglio@uantwerpen.be.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Zobrazit plný text záznamu
2
Akademický článek
mTOR inhibition in Q175 Huntington's disease model mice facilitates neuronal autophagy and mutant huntingtin clearance.
Autor: Stavrides P, Goulbourne CN, Peddy J, Huo C, Rao M, Khetarpal V, Marchionini DM, Nixon RA, Yang DS
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 May 30. Date of Electronic Publication: 2024 May 30.
Zobrazit plný text záznamu
3
Akademický článek
Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [ 11 C]CHDI-00485180-R and [ 11 C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin.
Autor: Delva A; Department of Neurosciences, KU Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals Leuven, Leuven, Belgium., Koole M; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Serdons K; Department of Radiopharmacy, University Hospitals Leuven, Leuven, Belgium., Bormans G; Lab Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Liu L; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Bard J; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Khetarpal V; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Dominguez C; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Wood A; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Skinbjerg M; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Wang Y; CHDI Management/CHDI Foundation, Princeton, NJ, 08540, USA., Vandenberghe W; Department of Neurosciences, KU Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals Leuven, Leuven, Belgium., Van Laere K; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. koen.vanlaere@uzleuven.be.; Division of Nuclear Medicine, University Hospitals Leuven, Leuven, België. koen.vanlaere@uzleuven.be.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Dec; Vol. 50 (1), pp. 48-60. Date of Electronic Publication: 2022 Aug 24.
Zobrazit plný text záznamu
4
Akademický článek
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease.
Autor: Bertoglio D; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium., Verhaeghe J; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium., Miranda A; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium., Wyffels L; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium., Stroobants S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium.; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium., Mrzljak L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Khetarpal V; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Skinbjerg M; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Liu L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Dominguez C; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Bard J; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Staelens S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp, Belgium. steven.staelens@uantwerpen.be.; μNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium. steven.staelens@uantwerpen.be.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Mar; Vol. 49 (4), pp. 1166-1175. Date of Electronic Publication: 2021 Oct 15.
Zobrazit plný text záznamu
5
Akademický článek
In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using 11 C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.
Autor: Bertoglio D; Bio-Imaging Lab, University of Antwerp, Antwerp, Belgium; daniele.bertoglio@uantwerpen.be weissa@ohsu.edu.; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium., Weiss AR; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon; daniele.bertoglio@uantwerpen.be weissa@ohsu.edu., Liguore W; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon., Martin LD; Division of Animal Resources and Research Support, Oregon National Primate Research Center, Beaverton, Oregon., Hobbs T; Division of Animal Resources and Research Support, Oregon National Primate Research Center, Beaverton, Oregon., Templon J; Center for Radiochemistry Research, Oregon Health and Science University, Portland, Oregon., Srinivasan S; Integrated Pathology Core, Oregon National Primate Research Center, Beaverton, Oregon., Dominguez C; CHDI Management/CHDI Foundation, Los Angeles, California; and., Munoz-Sanjuan I; CHDI Management/CHDI Foundation, Los Angeles, California; and., Khetarpal V; CHDI Management/CHDI Foundation, Los Angeles, California; and., Verhaeghe J; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium., Staelens S; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium., Link J; Center for Radiochemistry Research, Oregon Health and Science University, Portland, Oregon., Liu L; CHDI Management/CHDI Foundation, Los Angeles, California; and., Bard JA; CHDI Management/CHDI Foundation, Los Angeles, California; and., McBride JL; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon.; Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon.
Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Oct; Vol. 64 (10), pp. 1581-1587. Date of Electronic Publication: 2023 Aug 17.
Zobrazit plný text záznamu
6
Akademický článek
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease.
Autor: Liu L; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Malagu K; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Haughan AF; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Khetarpal V; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Stott AJ; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Esmieu W; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Vater HD; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Webster SJ; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Van de Poël AJ; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Clissold C; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Cosgrove B; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Sutton B; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Spencer JA; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Breccia P; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Gancia E; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Bonomo S; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Ladduwahetty T; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Lazari O; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Patel H; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Atton HC; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Clifton S; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Mota DM; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Magnani D; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., O'Neill A; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Stebbeds M; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Macabuag N; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Todd D; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Herva ME; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Mitchell P; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., Visser M; Charles River, Darwinweg 24, 2333 CR Leiden, The Netherlands., Compte Sancerni S; Charles River, Darwinweg 24, 2333 CR Leiden, The Netherlands., Grand Moursel L; Charles River, Darwinweg 24, 2333 CR Leiden, The Netherlands., da Silva M; Charles River, Darwinweg 24, 2333 CR Leiden, The Netherlands., Kritikou E; Charles River, Darwinweg 24, 2333 CR Leiden, The Netherlands., Heikkinen TT; Charles River, Microkatu 1, Kuopio 70210 Finland., Bolkvadze T; Charles River, Microkatu 1, Kuopio 70210 Finland., Fodale V; IRBM S.p.A., Pomezia, Roma 00071, Italy., Spadafora D; IRBM S.p.A., Pomezia, Roma 00071, Italy., Daldin M; IRBM S.p.A., Pomezia, Roma 00071, Italy., Bresciani A; IRBM S.p.A., Pomezia, Roma 00071, Italy., Mangette JE; Curia Global, Inc., Buffalo, New York 14203, United States., Doherty EM; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Lee MR; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Herbst T; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Monteagudo E; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Macdonald D; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Plotnikov NV; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Chambers M; Discovery from Charles River, Charles River, Chesterford Research Park, Saffron Walden CB10 1XL, U.K., McAllister G; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Muňoz-Sanjuan I; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States., Dominguez C; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, California 90045, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2023 Sep 28; Vol. 66 (18), pp. 13205-13246. Date of Electronic Publication: 2023 Sep 15.
Zobrazit plný text záznamu
7
Akademický článek
Validation of LC-MS/MS methods for quantitative analysis of kynurenine pathway metabolites in human plasma and cerebrospinal fluid.
Autor: Khetarpal V; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, CA 90045, USA., Herbst T; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, CA 90045, USA., Akhtar S; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., LaFayette A; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Miller D; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Farnham J; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Steege T; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Miao Z; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Marks B; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Ledvina A; Labcorp Early Development Laboratories, Inc., 3301 Kinsman Boulevard, Madison, WI 53704, USA., Dominguez C; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, CA 90045, USA.
Publikováno v: Bioanalysis [Bioanalysis] 2023 Jun; Vol. 15 (11), pp. 637-651. Date of Electronic Publication: 2023 May 12.
Zobrazit plný text záznamu
8
Akademický článek
Design and Evaluation of [ 18 F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates.
Autor: Liu L; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Johnson PD; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Prime ME; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Khetarpal V; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Brown CJ; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Anzillotti L; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Bertoglio D; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium., Chen X; Curia Global, Inc., 1001 Main Street, Buffalo, New York 14203, United States., Coe S; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Davis R; Curia Global, Inc., 1001 Main Street, Buffalo, New York 14203, United States., Dickie AP; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Esposito S; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Gadouleau E; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Giles PR; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Greenaway C; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Haber J; Curia Global, Inc., 1001 Main Street, Buffalo, New York 14203, United States., Halldin C; Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, Stockholm S-17176, Sweden., Haller S; Charles River Laboratories, 54943 North Main Street, Mattawan, Michigan 49071, United States., Hayes S; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Herbst T; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Herrmann F; Evotec SE, Manfred Eigen Campus, Essener Bogen 7, Hamburg 22419, Germany., Heßmann M; Evotec SE, Manfred Eigen Campus, Essener Bogen 7, Hamburg 22419, Germany., Hsai MM; Curia Global, Inc., 1001 Main Street, Buffalo, New York 14203, United States., Khani Y; Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, Stockholm S-17176, Sweden., Kotey A; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Lembo A; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Mangette JE; Curia Global, Inc., 1001 Main Street, Buffalo, New York 14203, United States., Marriner GA; Charles River Laboratories, 54943 North Main Street, Mattawan, Michigan 49071, United States., Marston RW; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Mills MR; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Monteagudo E; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Forsberg-Morén A; Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, Stockholm S-17176, Sweden., Nag S; Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Hospital, Karolinska Institutet, Stockholm S-17176, Sweden., Orsatti L; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Sandiego C; Invicro, 60 Temple St, Ste 8A, New Haven, Connecticut 06510, United States., Schaertl S; Evotec SE, Manfred Eigen Campus, Essener Bogen 7, Hamburg 22419, Germany., Sproston J; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Staelens S; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium., Tookey J; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Turner PA; Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, U.K., Vecchi A; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Veneziano M; Experimental Pharmacology Department, IRBM S.p.A., Via Pontina km 30,600, Pomezia, Roma 00071, Italy., Muñoz-Sanjuan I; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Bard J; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States., Dominguez C; CHDI Management/CHDI Foundation, 6080 Center Drive, Suite 700, Los Angeles, California 90045, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2023 Jan 12; Vol. 66 (1), pp. 641-656. Date of Electronic Publication: 2022 Dec 22.
Zobrazit plný text záznamu
9
Akademický článek
Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model.
Autor: Marchionini DM; CHDI Management/CHDI Foundation, New York, New York, USA., Liu JP; University of Virginia School of Medicine, Charlottesville, Virginia, USA., Ambesi-Impiombato A; Psychogenics Inc., Paramus, New Jersey, USA., Kerker K; Psychogenics Inc., Paramus, New Jersey, USA., Cirillo K; Psychogenics Inc., Paramus, New Jersey, USA., Bansal M; Psychogenics Inc., Paramus, New Jersey, USA., Mushlin R; Psychogenics Inc., Paramus, New Jersey, USA., Brunner D; Psychogenics Inc., Paramus, New Jersey, USA., Ramboz S; Psychogenics Inc., Paramus, New Jersey, USA., Kwan M; Psychogenics Inc., Paramus, New Jersey, USA., Kuhlbrodt K; Evotec SE, Hamburg, Germany., Tillack K; Evotec SE, Hamburg, Germany., Peters F; Evotec SE, Hamburg, Germany., Rauhala L; Charles River, Kuopio, Finland., Obenauer J; Rancho Biosciences, San Diego, California, USA., Greene JR; Rancho Biosciences, San Diego, California, USA., Hartl C; Rancho Biosciences, San Diego, California, USA., Khetarpal V; CHDI Management/CHDI Foundation, New York, New York, USA., Lager B; CHDI Management/CHDI Foundation, New York, New York, USA., Rosinski J; CHDI Management/CHDI Foundation, New York, New York, USA., Aaronson J; CHDI Management/CHDI Foundation, New York, New York, USA., Alam M; CHDI Management/CHDI Foundation, New York, New York, USA., Signer E; CHDI Management/CHDI Foundation, New York, New York, USA., Muñoz-Sanjuán I; CHDI Management/CHDI Foundation, New York, New York, USA., Howland D; CHDI Management/CHDI Foundation, New York, New York, USA., Zeitlin SO; University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Publikováno v: JCI insight [JCI Insight] 2022 Oct 24; Vol. 7 (20). Date of Electronic Publication: 2022 Oct 24.
Zobrazit plný text záznamu
10
Akademický článek
Modelling the Human Blood-Brain Barrier in Huntington Disease.
Autor: Vignone D; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Gonzalez Paz O; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Fini I; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Cellucci A; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Auciello G; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Battista MR; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Gloaguen I; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Fortuni S; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Cariulo C; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy., Khetarpal V; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA., Dominguez C; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA., Muñoz-Sanjuán I; CHDI Management/CHDI Foundation, 6080 Center Drive, Los Angeles, CA 90045, USA., Di Marco A; IRBM SpA, Via Pontina km 30,600, 00071 Pomezia, Italy.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Jul 15; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje